We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$622M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$597M
3
CMCSA icon
Comcast
CMCSA
+$461M
4
UNH icon
UnitedHealth
UNH
+$409M
5
MXIM
Maxim Integrated Products
MXIM
+$343M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INDF
9226
DELISTED
Nifty India Financials ETF
INDF
$625K ﹤0.01%
17,002
-508
-3% -$18.1K
KARS icon
9227
KraneShares Electric Vehicles and Future Mobility Index ETF
KARS
$81.6M
$624K ﹤0.01%
+13,437
New +$636K
APRE icon
9228
Aprea Therapeutics
APRE
$8.54M
$623K ﹤0.01%
6,097
+4,666
+326% +$424K
BAK icon
9229
Braskem
BAK
$801M
$623K ﹤0.01%
28,554
-23,603
-45% -$546K
PHAT icon
9230
Phathom Pharmaceuticals
PHAT
$751M
$623K ﹤0.01%
19,410
-60,964
-76% -$2.03M
VKTX icon
9231
PUT
Viking Therapeutics
VKTX
$3.92B
$623K ﹤0.01%
99,200
-8,600
-8% -$53.1K
RETA
9232
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$623K ﹤0.01%
+6,193
New +$726K
BURU
9233
CALL
DELISTED
NUBURU INC
BURU
$622K ﹤0.01%
+319
New +$622K
ESI icon
9234
Element Solutions
ESI
$9.56B
$622K ﹤0.01%
28,708
-297,032
-91% -$6.78M
WHD icon
9235
Cactus
WHD
$5.89B
$622K ﹤0.01%
16,489
-43,345
-72% -$1.56M
SCU
9236
CALL
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$622K ﹤0.01%
22,300
-4,200
-16% -$109K
AWI icon
9237
PUT
Armstrong World Industries
AWI
$7.57B
$621K ﹤0.01%
6,500
+2,400
+59% +$252K
GEF icon
9238
Greif
GEF
$4.97B
$621K ﹤0.01%
9,617
-34,203
-78% -$2.12M
OMER icon
9239
Omeros
OMER
$1.26B
$621K ﹤0.01%
45,047
-11,759
-21% -$176K
PXLW icon
9240
CALL
Pixelworks
PXLW
$41.1M
$621K ﹤0.01%
+10,833
New +$550K
CONN
9241
PUT
DELISTED
Conn's Inc.
CONN
$621K ﹤0.01%
27,200
-26,600
-49% -$632K
VCR icon
9242
PUT
Vanguard Consumer Discretionary ETF
VCR
$6.03B
$620K ﹤0.01%
2,000
-2,900
-59% -$921K
RPT
9243
Rithm Property Trust
RPT
$102M
$620K ﹤0.01%
+7,653
New +$615K
SCWX
9244
PUT
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$620K ﹤0.01%
31,200
+10,000
+47% +$207K
ACC
9245
PUT
DELISTED
American Campus Communities, Inc.
ACC
$620K ﹤0.01%
+12,800
New +$635K
ACT icon
9246
Enact Holdings
ACT
$6.84B
$619K ﹤0.01%
+28,215
New +$597K
CLVT icon
9247
Clarivate
CLVT
$1.21B
$619K ﹤0.01%
28,231
-570,529
-95% -$13.9M
KW
9248
PUT
DELISTED
Kennedy-Wilson Holdings
KW
$619K ﹤0.01%
29,600
-2,900
-9% -$60.4K
TR icon
9249
PUT
Tootsie Roll Industries
TR
$3.02B
$619K ﹤0.01%
23,578
-12,212
-34% -$344K
URGN icon
9250
CALL
UroGen Pharma
URGN
$2.4B
$619K ﹤0.01%
36,800
-700
-2% -$11.1K
368 369
370
371 372

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.